Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: Prevalence and characterization

Journal of Neurodevelopmental Disorders

Volumn 3, Issue 1, 2011, Pages 57-67

  Cordeiro, Lisa ^a,b   Ballinger, Elizabeth ^a,b   Hagerman, Randi ^a,c   Hessl, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Fragile X syndrome; Intellectual disability; Social phobia; Specific phobia

Indexed keywords

EID: 85128246040     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1007/s11689-010-9067-y     Document Type: Article

References (71)

1. Bailey Jr DB, Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. 2008; 146A(16): 2060-9.
2. Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008; 60(2): 201-14.
3. Berry-Kravis E, Potanos K. Psychopharmacology in fragile X syndrome-present and future. Ment Retard Dev Disabil Res Rev. 2004; 10(1): 42-8.
4. Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, et al. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet. 2009; 46(4): 266-71.
5. Bodden DH, Bogels SM, Nauta MH, De Haan E, Ringrose J, Appelboom C, et al. Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study. J Am Acad Child Adolesc Psychiatry. 2008; 47(12): 1384-94.
6. Bodden DH, Bogels SM, Muris P. The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Behav Res Ther. 2009; 47(5): 418-25.
7. Brady EU, Kendall PC. Comorbidity of anxiety and depression in children and adolescents. Psychol Bull. 1992; 111(2): 244-55.
8. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991; 100(3): 316-36.
9. Cohen IL, Sudhalter V, Pfadt A, Jenkins EC, Brown WT, Vietze PM. Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet. 1991; 48(2): 195-202.
10. Compton SN, Walkup JT, Albano AM, Piacentini JC, Birmaher B, Sherrill JT, et al. Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. Child Adolesc Psychiatr Ment Health. 2010; 4: 1.
11. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003; 60(8): 837-44.
12. Crawford DC, Meadows KL, Newman JL, Taft LF, Scott E, Leslie M, et al. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002; 110(3): 226-33.
13. de Bruin EI, Ferdinand RF, Meester S, de Nijs PF, Verheij F. High rates of psychiatric co-morbidity in PDD-NOS. J Autism Dev Disord. 2007; 37(5): 877-86.
14. Dekker MC, Koot HM. DSM-IV disorders in children with borderline to moderate intellectual disability. I: prevalence and impact. J Am Acad Child Adolesc Psychiatry. 2003; 42(8): 915-22.
15. Dykens EM. Anxiety, fears, and phobias in persons with Williams syndrome. Dev Neuropsychol. 2003; 23(1-2): 291-316.
16. Eaton LF, Menolascino FJ. Psychiatric disorders in the mentally retarded: types, problems, and challenges. Am J Psychiatry. 1982; 139(10): 1297-303.
17. Einfeld SL, Tonge BJ, Rees VW. Longitudinal course of behavioral and emotional problems in Williams syndrome. Am J Ment Retard. 2001; 106(1): 73-81.
18. Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. J Autism Dev Disord. 2003; 33(6): 617-29.
19. Farzin F, Rivera S, Hessl D. Brief report: visual processing of faces in individuals with fragile X syndrome: an eye tracking study. J Autism Dev Disord. 2009; 39(6): 946-52.
20. Fergusson DM, Horwood LJ, Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15year olds. J Am Acad Child Adolesc Psychiatry. 1993; 32(6): 1127-34.
21. Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn. 2009; 11(4): 324-9.
22. Freund LS, Reiss AL, Abrams MT. Psychiatric disorders associated with fragile X in the young female. Pediatrics. 1993; 91(2): 321-9.
23. Gillott A, Furniss F, Walter A. Anxiety in high-functioning children with autism. Autism. 2001; 5(3): 277.
24. Gosch A, Pankau R. Personality characteristics and behaviour problems in individuals of different ages with Williams syndrome. Dev Med Child Neurol. 1997; 39(8): 527-33.
25. Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, van Stone E, et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11. 2 deletion syndrome. Am J Psychiatry. 2007; 164(4): 663-9.
26. Haas B, Barnea-Goraly N, Lightbody A, Patnaik S, Hoeft F, Hazlett H, et al. Early white-matter abnormalities of the ventral frontostriatal pathway in fragile X syndrome. Dev Med Child Neurol. 2009; 51(8): 593-9.
27. Hagan CC, Hoeft F, Mackey A, Mobbs D, Reiss AL. Aberrant neural function during emotion attribution in female subjects with fragile X syndrome. J Am Acad Child Adolesc Psych. 2008; 47(12): 1443.
28. Hagerman PJ. The fragile X prevalence paradox. J Med Genet. 2008; 45(8): 498-9.
29. Hagerman RJ, Hills J, Scharfenaker S, Lewis H. Fragile X syndrome and selective mutism. Am J Med Genet. 1999; 83(4): 313-7.
30. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, et al. Advances in the treatment of fragile X syndrome. Pediatrics. 2009; 123(1): 378-90.
31. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, et al. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008; 113(6): 427-38.
32. Hessl D, Dyer-Friedman J, Glaser B, Wisbeck J, Barajas RG, Taylor A, et al. The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. Pediatrics. 2001; 108(5): E88.
33. Hessl D, Glaser B, Dyer-Friedman J, Blasey C, Hastie T, Gunnar M, et al. Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology. 2002; 27(7): 855-72.
34. Hessl D, Glaser B, Dyer-Friedman J, Reiss AL. Social behavior and cortisol reactivity in children with fragile X syndrome. J Child Psychol Psychiatry. 2006; 47(6): 602-10.
35. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 593-602.
36. Lachiewicz AM. Abnormal behaviors of young girls with fragile X syndrome. Am J Med Genet. 1992; 43(1-2): 72-7.
37. Lachiewicz A. Females with fragile X syndrome: a review of the effects of an abnormal gene. Ment Retard Dev Disabil Res Rev. 1995; 1: 292-7.
38. Lachiewicz AM, Dawson DV. Behavior problems of young girls with fragile X syndrome: factor scores on the Conners' Parent's Questionnaire. Am J Med Genet. 1994; 51(4): 364-9.
39. Lachiewicz AM, Dawson DV, Spiridigliozzi GA, McConkie-Rosell A. Arithmetic difficulties in females with the fragile X premutation. Am J Med Genet A. 2006; 140(7): 665-72.
40. Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006a; 20(4): 444-58.
41. Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, Fricke JS, Mervis CB. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet. 2006b; 141B(6): 615-22.
42. Leyfer O, Woodruff-Borden J, Mervis CB. Anxiety disorders in children with Williams syndrome, their mothers, and their siblings: implications for the etiology of anxiety disorders. J Neurodevelopmental Disord. 2009; 1(1): 4-14.
43. Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004; 10(1): 31-41.
44. Lyneham HJ, Abbott MJ, Rapee RM. Interrater reliability of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent version. J Am Acad Child Adolesc Psychiatry. 2007; 46(6): 731-6.
45. Markham J, Beckel-Mitchener A, Estrada C, Greenough W. Corticosterone response to acute stress in a mouse model of Fragile X syndrome. Psychoneuroendocrinology. 2006; 31(6): 781-5.
46. McGee R, Feehan M, Williams S, Partridge F, Silva PA, Kelly J. DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry. 1990; 29(4): 611-9.
47. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet. 1999; 83(4): 268-79.
48. Murphy MM. A review of mathematical learning disabilities in children with fragile X syndrome. Dev Disabil Res Rev. 2009; 15(1): 21-7.
49. Myers BA, Pueschel SM. Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis. 1991; 179(10): 609-13.
50. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998a; 17(8): 873-90.
51. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998b; 17(8): 857-72.
52. Panichelli-Mindel SM, Flannery-Schroeder E, Kendall PC, Angelosante AG. Disclosure of distress among anxiety-disordered youth: differences in treatment outcome. J Anxiety Disord. 2005; 19(4): 403-22.
53. Prasad SE, Howley S, Murphy KC. Candidate genes and the behavioral phenotype in 22q11. 2 deletion syndrome. Dev Disabil Res Rev. 2008; 14(1): 26-34.
54. Reiss AL, Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet. 1992; 43(1-2): 35-46.
55. Reiss S, Valenti-Hein D. Development of a psychopathology rating scale for children with mental retardation. J Consult Clin Psychol. 1994; 62(1): 28-33.
56. Roberts JE, Boccia ML, Bailey DB, Hatton D, Skinner M. Cardiovascular indices of physiological arousal in boys with fragile X syndrome. Dev Psychobiol. 2001; 39(2): 107-23.
57. Ross CJ, Davis TM, Hogg DY. Screening and assessing adolescent asthmatics for anxiety disorders. Clin Nurs Res. 2007; 16(1): 5-24. discussion 5-8.
58. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, et al. The NIMH Diagnostic Interview Schedule for Children Version 2. 3 (DISC-2. 3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the epidemiology of child and adolescent mental disorders study. J Am Acad Child Adolesc Psychiatry. 1996; 35(7): 865-77.
59. Silverman WK, Albano AM. Anxiety Disorders Interview Schedule (ADIS-IV) child/parent clinician manual. New York: Oxford University Press; 2004.
60. Silverman WK, Saavedra LM, Pina AA. Test-retest reliability of anxiety symptoms and diagnoses with the anxiety disorders interview schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psych. 2001; 40(8): 937-44.
61. Simon E, Bogels SM. Screening for anxiety disorders in children. Eur Child Adolesc Psychiatry. 2009; 18(10): 625-34.
62. Sobesky WE, Pennington BF, Porter D, Hull CE, Hagerman RJ. Emotional and neurocognitive deficits in fragile X. Am J Med Genet. 1994; 51(4): 378-85.
63. Spencer C, Alekseyenko O, Serysheva E, Yuva-Paylor L, Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 2005; 4(7): 420-30.
64. SPSS Statistics 17. 0 Algorithms manual. Chicago, IL2007.
65. SPSS Statistics 17. 0 Command Syntax Reference manual. Chicago, IL. 2007.
66. Stark KD, Laurent J. Joint factor analysis of the children's depression inventory and the revised children's manifest anxiety scale. J Clin Child Psychol. 2001; 30(4): 552-67.
67. Sudhalter V, Cohen IL, Silverman W, Wolf-Schein EG. Conversational analyses of males with fragile X, Down syndrome, and autism: comparison of the emergence of deviant language. Am J Ment Retard. 1990; 94(4): 431-41.
68. Thaler NS, Kazemi E, Wood JJ. Measuring Anxiety in Youth with Learning Disabilities: Reliability and Validity of the Multidimensional Anxiety Scale for Children (MASC). Child Psychiatry Hum Dev. 2010; 41(5): 501-14.
69. Viana AG, Beidel DC, Rabian B. Selective mutism: a review and integration of the last 15years. Clin Psychol Rev. 2009; 29(1): 57-67.
70. Waters AM, Mogg K, Bradley BP, Pine DS. Attentional bias for emotional faces in children with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2008; 47(4): 435-42.
71. White SW, Oswald D, Ollendick T, Scahill L. Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev. 2009; 29(3): 216-29.